LONDON--(BUSINESS WIRE)--The incidence of drug-induced liver injuries is increasing at a significant rate across the world. Drugs can have an adverse effect on the functioning of the liver and can lead to symptoms such as abdominal pain, jaundice, and itching. Thus, the demand for bilirubin blood tests to monitor drug-induced liver injuries is increasing, as they exhibit high bilirubin levels. Therefore, the rising incidence of drug-induced injuries will have a significant impact on the growth of the bilirubin blood test market during the forecast period. Furthermore, this industry research report also presents a competitive analysis of the market by application (infants and adults) and geography (Asia, Europe, North America, and ROW).
Competitive vendor landscape
The global bilirubin blood test market is highly competitive with major vendors such as Advanced Instruments, Danaher, F. Hoffmann-La Roche Ltd, Koninklijke Philips N.V., and Thermo Fisher Scientific Inc, competing on the basis of price, quality, and market presence.
“The popularity of hand-held diagnostic devices is increasing significantly as they can be used by laboratory professionals at any location of the medical facility. The handheld devices such as portable bilirubinometers are smaller, and lighter, and hence, they can be used to check bilirubin levels in newborns. They can also eliminate the hassle of packaging and transport, thus leading to their increased demand over conventional bilirubinometers. Therefore, the growing demand for handheld devices will fuel the growth of the market during the forecast period,” says a senior analyst at Technavio.
Top five bilirubin blood test market vendors
Advanced Instruments offers instrumentation for clinical, pharmaceutical, biotechnology, and microbiology laboratories worldwide. Its product portfolio includes freezing point osmometers, calibration standards, reference solutions, osmometer consumables, and linearity sets. The company offers BR2 Bilirubin Stat-Analyzer, which can be used to measure both total and direct bilirubin levels in neonates, using only a 30µL serum sample.
Danaher is one of the most established companies in the world with businesses in various segments including life sciences, diagnostics, dental, and environmental and applied solutions. The company’s key offerings in the bilirubin blood test market include UniCel DxC 800 Synchron clinical systems that minimizes workflow interruptions and maximizes user-friendliness. It delivers faster results with a reliable turnaround time.
F. Hoffmann-La Roche Ltd
F. Hoffmann-La Roche Ltd manufactures equipment and reagents for research and medical diagnostic applications. Under the bilirubin blood test category, the company offers Bilirubin Direct Gen.2, which is offered as an assay for in-vitro tests for the quantitative determination of direct bilirubin concentration in human serum and plasma.
Koninklijke Philips N.V.
Koninklijke Philips N.V. has business operations in various segments including personal health, diagnosis and treatment, connected care and health informatics. The company offers BiliChek System, which is a non-invasive, transcutaneous bilirubinometer used to measure bilirubin levels.
Thermo Fisher Scientific Inc.
Thermo Fisher Scientific Inc. offers sample preparation and preservation equipment, controlled temperature technology products, water analysis instruments, centrifugation products, and biological safety cabinets. The company’s key offerings in the bilirubin blood test market include Total bilirubin reagents, which are used to determine the quantity of total bilirubin in serum samples.
Looking for more information on this market? Request a free sample report
Technavio’s sample reports are free of charge and contain multiple sections of the report including the market size and forecast, drivers, challenges, trends, and more.
Browse Related Reports:
- Global C-Reactive Protein Test Market 2019-2023 - The market research study identifies Abbott, Danaher, F Hoffmann-La Roche Ltd, Merck KGaA, and Thermo Fisher Scientific Inc., as the leading players in the global C-reactive protein test market.
- Global Anti-Thrombin III Testing Market 2019-2023 - The market research study identifies Abbott Laboratories, Danaher Corp., F. Hoffmann-La Roche Ltd., Siemens Healthcare GmbH, and Thermo Fisher Scientific Inc., as the leading players in the global anti-thrombin III testing market.
Technavio is a leading global technology research and advisory company. Their research and analysis focuses on emerging market trends and provides actionable insights to help businesses identify market opportunities and develop effective strategies to optimize their market positions.
With over 500 specialized analysts, Technavio’s report library consists of more than 10,000 reports and counting, covering 800 technologies, spanning across 50 countries. Their client base consists of enterprises of all sizes, including more than 100 Fortune 500 companies. This growing client base relies on Technavio’s comprehensive coverage, extensive research, and actionable market insights to identify opportunities in existing and potential markets and assess their competitive positions within changing market scenarios.
If you are interested in more information, please contact our media team at email@example.com.